Exponent Inc
SWB:EP5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exponent Inc
SWB:EP5
|
US |
|
J
|
JTL Industries Ltd
BSE:534600
|
IN |
|
Innate Pharma SA
PAR:IPH
|
FR |
|
A
|
ADTRAN Holdings Inc
XMUN:QH9
|
US |
|
M
|
McEwen Mining Inc
XETRA:US8A
|
CA |
Wall St Price Targets
EP5 Price Targets Summary
Exponent Inc
According to Wall Street analysts, the average 1-year price target for EP5 is 71.53 EUR with a low forecast of 64.39 EUR and a high forecast of 80.32 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EP5's stock price target?
Price Target
71.53
EUR
According to Wall Street analysts, the average 1-year price target for EP5 is 71.53 EUR with a low forecast of 64.39 EUR and a high forecast of 80.32 EUR.
What is the Revenue forecast for Exponent Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Exponent Inc?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Exponent Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 9%.
